4.6 Article

A novel HCC prognosis predictor PDSS1 affects the cell cycle through the STAT3 signaling pathway in HCC

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy

Manlio Tolomeo et al.

Summary: STAT3 is a complex regulator of transcription, with constitutive activation reported in many tumors but less frequent somatic mutations in cancer. Oncogenic targets of STAT3 have been identified, and inhibitors have been developed for cancer prevention and treatment. However, data suggest that STAT3 functions are multifaceted and its cellular role is determined by various signals and factors, making targeted therapies tailored to specific tumor types important.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Clinical Neurology

Missense PDSS1 mutations in CoenzymeQ10 synthesis cause optic atrophy and sensorineural deafness

Francesca Nardecchia et al.

Summary: The article describes two sisters who experienced sensorineural deafness followed by optic atrophy due to a novel homozygous pathogenic variant in PDSS1. This suggests that the visual system is primarily affected when the initial steps of CoQ10 synthesis are impaired.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Review Genetics & Heredity

HMGA2 as a Critical Regulator in Cancer Development

Behzad Mansoori et al.

Summary: HMGA2 is a DNA architectural protein that regulates gene expression and is highly expressed in embryonic stem cells during development but re-expressed in most human malignancies, where it plays a critical role in promoting tumorigenesis through various mechanisms. HMGA2 increases cancer cell proliferation and resistance to chemotherapy, and influences DNA repair mechanisms and epithelial-to-mesenchymal transition, suggesting its potential as a diagnostic, prognostic, and therapeutic target in cancer.

GENES (2021)

Review Oncology

IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma

Junnv Xu et al.

Summary: IL-6 plays a crucial role in the occurrence and development of hepatocellular carcinoma (HCC), and targeting the IL-6/STAT3 signaling pathway is essential for therapy. Several inhibitors of IL-6/STAT3 have been developed for cancer treatment.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8+ T Cell Response in Hepatocellular Carcinoma

Julia Pena-Asensio et al.

Summary: The cytotoxic T cell response against hepatocellular carcinoma antigens is exhausted, but can be restored by blocking negative immune checkpoints. Combinatory strategies based on anti-PD-1 are being studied to enhance the therapeutic effect.

CANCERS (2021)

Review Oncology

Natural Killer-Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy

Valentina Cazzetta et al.

Summary: The reciprocal crosstalk between dendritic cells (DCs) and natural killer (NK) cells plays a crucial role in regulating immune defense against viruses and tumors, with potential therapeutic implications in liver malignancies. NK cells and DCs are innate immune cells that interact to control activation and immune responses, particularly in the context of liver cancer.

CANCERS (2021)

Article Oncology

PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer

Tian-Jian Yu et al.

Summary: The study identifies PDSS1 as an essential gene for TNBC metastasis, with its expression correlated with poor survival in patients. Mechanistically, PDSS1 regulates TNBC metastasis by modulating CoQ10 levels and CAMK2A phosphorylation to induce STAT3 signaling. Inhibitors of STAT3 phosphorylation effectively block PDSS1-induced cell migration and invasion, highlighting PDSS1 as a potential therapeutic target in combating TNBC metastasis.

CANCER RESEARCH (2021)

Review Oncology

Immunity beyond cancer cells: perspective from tumor tissue

Shengyu Gao et al.

Summary: Research has shown that the cancer environment plays a crucial role in controlling the manifestation of cancerous cell phenotype, while Th cells play important roles in immune defense, impacting tumor microenvironment and stroma reconfiguration. Both Th1 and Th2 cells exert anticancer effects through different mechanisms, suggesting potential for novel cancer environment immunotherapy approaches to be developed.

TRENDS IN CANCER (2021)

Review Cell Biology

The Roles of CD8(+) T Cell Subsets in Antitumor Immunity

Michael St Paul et al.

TRENDS IN CELL BIOLOGY (2020)

Review Gastroenterology & Hepatology

Goals and targets for personalized therapy for HCC

Thomas Couri et al.

HEPATOLOGY INTERNATIONAL (2019)

Article Biochemical Research Methods

GSCALite: a web server for gene set cancer analysis

Chun-Jie Liu et al.

BIOINFORMATICS (2018)

Review Medicine, General & Internal

Hepatocellular carcinoma

Alejandro Forner et al.

LANCET (2018)

Article Multidisciplinary Sciences

Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma

Nataliya Rohr-Udilova et al.

SCIENTIFIC REPORTS (2018)

Article Genetics & Heredity

HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas

Qiuyu Lian et al.

GENOMICS PROTEOMICS & BIOINFORMATICS (2018)

Review Medicine, General & Internal

Hepatitis C virus-induced hepatocellular carcinoma: a narrative review

Maja Ruzic et al.

PANMINERVA MEDICA (2018)

Review Multidisciplinary Sciences

Elements of cancer immunity and the cancer-immune set point

Daniel S. Chen et al.

NATURE (2017)

Review Immunology

Tumor infiltrating immune cells in gliomas and meningiomas

Patricia Domingues et al.

BRAIN BEHAVIOR AND IMMUNITY (2016)

Article Oncology

Recent Progress in Understanding, Diagnosing, and Treating Hepatocellular Carcinoma

Mary Maluccio et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2012)

Review Oncology

Cancer immunotherapy via dendritic cells

Karolina Palucka et al.

NATURE REVIEWS CANCER (2012)

Article Gastroenterology & Hepatology

Interleukin-22 Promotes Human Hepatocellular Carcinoma by Activation of STAT3

Runqiu Jiang et al.

HEPATOLOGY (2011)

Article Multidisciplinary Sciences

Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer How Intimate Is the Relationship?

Bharat B. Aggarwal et al.

NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS (2009)

Article Biochemistry & Molecular Biology

Characterization of solanesyl and decaprenyl diphosphate synthases in mice and humans

R Saiki et al.

FEBS JOURNAL (2005)

Review Oncology

Tumor antigen-specific T helper cells in cancer immunity and immunotherapy

KL Knutson et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)

Review Biochemistry & Molecular Biology

STAT proteins: novel molecular targets for cancer drug discovery

J Turkson et al.

ONCOGENE (2000)